Nemysis

About:

A start-up tackling iron deficiency/anemia and gluten intolerance.

Top Investors: European Innovation Council

Description:

Nemysis unique strategy is a staged approach to the development of OTC and Prescription Products, tackling the same conditions to commercialise in different market segments. Nemysis is developing Food Supplements, Medical Matrix and Prescription products based on this strategy.

Total Funding Amount:

6.15M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2015-01-01

Contact Email:

valenti(AT)nemysisltd.com

Founders:

Danilo Casadei Massari

Number of Employees:

1-10

Last Funding Date:

2023-03-30

IPO Status:

Private

Industries: